Literature DB >> 17986374

Soluble CD14: role in atopic disease and recurrent infections, including otitis media.

Karin C Lødrup Carlsen1, Berit Granum.   

Abstract

Soluble CD14 (sCD14) is a part of innate immunity that has been implicated in many diseases, including allergic diseases. However, many influencing factors and confounders, including gender-gene-environment interactions, may complicate interpretations of the observed associations to allergic diseases. In this paper, we review current literature describing the functions of sCD14 and its associations with common (recurrent) infections and with allergic diseases. Because sCD14 is involved with immunologic responses to infections, and exposure to microbial compounds is debated as a protective or a trigger factor for allergy development, these factors-which include genotypes, gender, age, microbial agents (from the environment and infection), and tobacco smoke-cannot be assessed independently. We conclude that confounding effects are important and must be considered to understand the role of sCD14 in allergic development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986374     DOI: 10.1007/s11882-007-0067-2

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  75 in total

Review 1.  Evaluation of CD14 in host defence.

Authors:  P Antal-Szalmás
Journal:  Eur J Clin Invest       Date:  2000-02       Impact factor: 4.686

2.  Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients.

Authors:  C Ward; E H Walters; L Zheng; H Whitford; T J Williams; G I Snell
Journal:  Eur Respir J       Date:  2002-03       Impact factor: 16.671

3.  Soluble CD14 acts as a negative regulator of human T cell activation and function.

Authors:  J E Rey Nores; A Bensussan; N Vita; F Stelter; M A Arias; M Jones; S Lefort; L K Borysiewicz; P Ferrara; M O Labéta
Journal:  Eur J Immunol       Date:  1999-01       Impact factor: 5.532

4.  Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort study.

Authors:  D Rothenbacher; M Weyermann; C Beermann; H Brenner
Journal:  Clin Exp Allergy       Date:  2005-08       Impact factor: 5.018

5.  Opposite relationship between circulating soluble CD14 concentration and endothelial function in diabetic and nondiabetic subjects.

Authors:  José-Manuel Fernández-Real; Abel López-Bermejo; Antoni Castro; Montserrat Broch; Georgina Peñarroja; Joan Vendrell; Gabriel Vázquez; Wifredo Ricart
Journal:  Thromb Haemost       Date:  2005-09       Impact factor: 5.249

6.  Interleukin 4 down-regulates the expression of CD14 in normal human monocytes.

Authors:  R P Lauener; S M Goyert; R S Geha; D Vercelli
Journal:  Eur J Immunol       Date:  1990-11       Impact factor: 5.532

7.  Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria.

Authors:  Karine Vidal; Anne Donnet-Hughes; Dominique Granato
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

8.  Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14.

Authors:  I Striz; L Zheng; Y M Wang; H Pokorná; P C Bauer; U Costabel
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

9.  CD14 is an acute-phase protein.

Authors:  Sylvette Bas; Benoit R Gauthier; Ursula Spenato; Sybille Stingelin; Cem Gabay
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

10.  Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age.

Authors:  Stefano Guerra; I Carla Lohman; Marilyn Halonen; Fernando D Martinez; Anne L Wright
Journal:  Am J Respir Crit Care Med       Date:  2003-10-02       Impact factor: 21.405

View more
  6 in total

1.  Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles.

Authors:  G Thomas Brown; Thomas M McIntyre
Journal:  J Immunol       Date:  2011-03-23       Impact factor: 5.422

2.  Lipopolysaccharide is a direct agonist for platelet RNA splicing.

Authors:  Pavel N Shashkin; G Thomas Brown; Arundhati Ghosh; Gopal K Marathe; Thomas M McIntyre
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

3.  Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.

Authors:  Sofie Jespersen; Karin Kæreby Pedersen; Birgitta Anesten; Henrik Zetterberg; Dietmar Fuchs; Magnus Gisslén; Lars Hagberg; Marius Trøseid; Susanne Dam Nielsen
Journal:  BMC Infect Dis       Date:  2016-04-21       Impact factor: 3.090

4.  Association of plasma soluble CD14 level with asthma severity in adults: a case control study in China.

Authors:  Ting Zhou; Xiji Huang; Jixuan Ma; Yun Zhou; Yuewei Liu; Lili Xiao; Jing Yuan; Jungang Xie; Weihong Chen
Journal:  Respir Res       Date:  2019-01-28

5.  Intestinal barrier dysfunction mediates Whipple's disease immune reconstitution inflammatory syndrome (IRIS).

Authors:  Julian Friebel; Katina Schinnerling; Anika Geelhaar-Karsch; Kristina Allers; Thomas Schneider; Verena Moos
Journal:  Immun Inflamm Dis       Date:  2022-05

6.  Winter ambient training conditions are associated with increased bronchial hyperreactivity and with shifts in serum innate immunity proteins in young competitive speed skaters.

Authors:  Marcin Kurowski; Janusz Jurczyk; Sylwia Moskwa; Marzanna Jarzębska; Hubert Krysztofiak; Marek L Kowalski
Journal:  Arch Med Sci       Date:  2017-12-19       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.